{"id":7088,"date":"2025-05-22T13:54:05","date_gmt":"2025-05-22T10:54:05","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7088"},"modified":"2025-05-22T13:54:05","modified_gmt":"2025-05-22T10:54:05","slug":"in-patients-with-intermediate-cardiovascular-risk-and-impaired-renal-function-choosing-the-appropriate-risk-assessment-strategy-requires-balancing-diagnostic-accuracy-with-renal-safety-i-e-avoidin","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/in-patients-with-intermediate-cardiovascular-risk-and-impaired-renal-function-choosing-the-appropriate-risk-assessment-strategy-requires-balancing-diagnostic-accuracy-with-renal-safety-i-e-avoidin\/","title":{"rendered":"In patients with intermediate cardiovascular risk and impaired renal function, choosing the appropriate risk assessment strategy requires balancing diagnostic accuracy with renal safety (i.e., avoiding contrast-induced nephropathy)."},"content":{"rendered":"<div>In patients with intermediate cardiovascular risk and impaired renal function, choosing the appropriate risk assessment strategy requires balancing diagnostic accuracy with renal safety (i.e., avoiding contrast-induced nephropathy).<\/div>\n<div><\/div>\n<div>Recommended approach:<\/div>\n<div><span> 1. Start with non-contrast tools:<\/span><\/div>\n<div><span> \u2022 CAC Score (Coronary Artery Calcium) via non-contrast cardiac CT is safe in CKD stages 2\u20133 and provides strong negative predictive value.<\/span><\/div>\n<div><span> \u2022 If CAC = 0, the patient may be reclassified to low risk, avoiding unnecessary therapy.<\/span><\/div>\n<div><span> \u2022 If CAC &gt;0, especially &gt;100, intensification of preventive measures (e.g. statins) is often warranted.<\/span><\/div>\n<div><span> 2. Avoid contrast-enhanced CT angiography (CCTA):<\/span><\/div>\n<div><span> \u2022 Generally avoided in patients with eGFR &lt; 30 mL\/min\/1.73 m\u00b2 unless clinically essential and hydration protocols can be applied.<\/span><\/div>\n<div><span> 3. Use biomarkers and clinical scores:<\/span><\/div>\n<div><span> \u2022 SCORE2 or ASCVD Risk Estimator Plus (without imaging) may guide initial decisions.<\/span><\/div>\n<div><span> \u2022 hs-CRP, lipoprotein(a), or ApoB may add value in selected cases.<\/span><\/div>\n<div><span> 4. Carotid ultrasound:<\/span><\/div>\n<div><span> \u2022 A practical, contrast-free tool to assess subclinical atherosclerosis in high-risk individuals.<\/span><\/div>\n<div><span> \u2022 Detection of carotid plaques can reclassify a patient\u2019s risk upwards.<\/span><\/div>\n<div><span> 5. Emerging role of PET\/MRI or MR vessel wall imaging:<\/span><\/div>\n<div><span> \u2022 Research-based for now, but may offer future non-nephrotoxic options for plaque characterization.<\/span><\/div>\n<div><\/div>\n<div>\u2e3b<\/div>\n<div><\/div>\n<div>Conclusion:<\/div>\n<div>For a patient with moderate cardiovascular risk and impaired renal function, CAC scoring remains the best validated and safest imaging option. Carotid ultrasound is a valuable adjunct, and combining clinical scores with imaging helps refine decisions without harming kidney function.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In patients with intermediate cardiovascular risk and impaired renal function, choosing the appropriate risk assessment strategy requires balancing diagnostic accuracy with renal safety (i.e., avoiding contrast-induced nephropathy). Recommended approach: 1. Start with non-contrast tools: \u2022 CAC Score (Coronary Artery Calcium) via non-contrast cardiac CT is safe in CKD stages 2\u20133 and provides strong negative predictive [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7088","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7088"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7088\/revisions"}],"predecessor-version":[{"id":7089,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7088\/revisions\/7089"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}